Dasatinib treatment can overcome imatinib and nilotinib resistance in CML patient carrying F359I mutation of BCR-ABL oncogene - Concepedia

Concepedia

Publication | Closed Access

Dasatinib treatment can overcome imatinib and nilotinib resistance in CML patient carrying F359I mutation of BCR-ABL oncogene

24

Citations

9

References

2008

Year

Marta Barańska, Krzysztof Lewandowski, Michał Gniot, Małgorzata Iwoła, Maria Lewandowska, Mieczysław Komarnicki

Journal of Applied Genetics

F359i MutationChromatinNilotinib ResistanceHematological MalignancyHealth SciencesDasatinib TreatmentMedicineImmunologyHematologyPathologyMyeloid NeoplasiaCancer GeneticsMolecular DiagnosticsDrug Resistance

References

	Year	Citations

Page 1

Page 1